The Rh blood group system: A review

Blood

Volumn 95, Issue 2, 2000, Pages 375-387

  Avent, Neil D ^a,b   Reid, Marion E ^b  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY; ERYTHROCYTE BAND 3 PROTEIN; GLYCOPHORIN B; GLYCOPROTEIN; INTEGRIN; RHESUS ANTIGEN;

ANTIGEN EXPRESSION; BLOOD GROUP RH; EPITOPE MAPPING; ERYTHROCYTE MEMBRANE; GENE REARRANGEMENT; GENOTYPE; HEMOLYTIC ANEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; MYELOID LEUKEMIA; NEWBORN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0034651012     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.2.375     Document Type: Review

References (211)

1. Levine P, Stetson RE. An unusual case of intragroup agglutination. JAMA. 1939;113:126-127.
2. Landsteiner K, Wiener AS. An agglutinable factor in human blood recognized by immune sera for rhesus blood. Proc Soc Exp Biol Med. 1940;43: 223.
3. Rsk RT, Foord AG. Observations on the Rh agglutinogen of human blood. Am J Clin Pathol. 1942:12:545-552.
4. Levine P, Celano MJ, Wallace J, Sanger R. A human 'D-like' antibody. Nature. 1963;198:596-597.
5. Daniels GL, Anstee DJ. Cartron J-P, et al. Blood group terminology 1995: ISBT working party on terminology for red cell surface antigens. Vox Sang. 1995:69:265-279.
6. Rosenfield RE, Alien FH Jr, Swisher SN, Kochwa S. A review of Rh serology and presentation of a new terminology. Transfusion. 1962;2:287-312.
7. Rosenfield RE, Alien FH Jr, Rubinstein P. Genetic model for the Rh blood-group system. Proc Natl Acad Sei U S A. 1973;70:1303-1307.
8. Allen FH Jr, Rosenfield RE. Review of Rh serology: eight new antigens in nine years. Haematologia. 1972;6:113-120.
9. Rosenfield RE, Alien FH Jr, Swisher SN, Kochwa S. Rh nomenclature. Transfusion. 1979:19:487.
10. Moore S, Woodrow CF, McClelland DB. Isolation of membrane components associated with human red cell antigens Rh(D), (c), (E) and Fy. Nature. 1982;295:529-531.
11. O (D) antigen. FEES Lett. 1982;140:9397.
12. Moore S, Green C. The identification of specific Rhesus polypeptide blood group ABH-active glycoprotein complexes in the human red-cell membrane. Biochem J. 1987:244:735-741.
13. Agre P, Cartron J-P. Molecular biology of the Rh antigens. Blood. 1991;78:551-563.
14. Anstee DJ, Tanner MJ. Biochemical aspects of the blood group Rh (rhesus) antigens. Baillieres Clin Haematol. 1993:6:401-422.
15. Moore S, Gahmberg CG. Identification of Rh polypeptide and Rh polypeptide/Rh glycoprotein complexes. Biotest Bull. 1997;5:409-413.
16. Huang C-H. Molecular insights into the Rh protein family and associated antigens. Curr Opin Hematol. 1997;4:94-103.
17. Ridgwell K, Spurr NK, Laguda B, MacGeoch C, Avent ND, Tanner MJ. Isolation of cDNA clones for a 50 kDa glycoprotein of the human erythrocyte membrane associated with Rh (rhesus) blood-group antigen expression. Biochem J. 1992;287:223-228.
18. Eyers SA, Ridgwell K, Mawby WJ, Tanner MJ. Topology and organization of human Rh (rhesus) blood group-related polypeptides. J Biol Chem. 1994:269:6417-6423.
19. Avent ND, Liu W, Warner KM, et al. Immunochemical analysis of the human erythrocyte Rh polypeptides. J Biol Chem. 1996;271:14,233-14,239.
20. Avent ND, Ridgwell K, Tanner MJA, Anstee DJ. cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-bloodgroup-antigen expression. Biochem J. 1990;271: 821-825.
21. Chérif-Zahar B. Le Van Kim C, Rouillac C, Raynal V, Cartron J-P, Colin Y. Organization of the gene (RHCE) encoding the human blood group RhC-cEe antigens and characterization of the promoter region. Genomics. 1994:19:68-74.
22. null disease. J Biol Chem. 1998:273:2207-2213.
23. Avent ND, Butcher SK, Uu W, et al. Localization of the C termini of the Rh (rhesus) polypeptides to the cytoplasmic face of the human erythrocyte membrane. J Biol Chem. 1992:267:15,134-15,139.
24. Hermand P, Mouro I, Huet M, et al. Immunochemical characterization of rhesus proteins with antibodies raised against synthetic peptides. Blood. 1993:82:669-676.
25. Cartron JP, Bailly P, Le Van Kim C, et al. Insights into the structure and function of membrane poly-peptides carrying blood group antigens. Vox Sang. 1998;74(suppl 2):29-64.
26. Hartel-Schenk S, Agre P. Mammalian red cell membrane Rh polypeptides are selectively palmitoylated subunits of a macromolecular complex. J Biol Chem. 1992:267:5569-5574.
27. 279 - >Glu missense mutation in the conserved transmembrane segment. Blood. 1998:92:1776-1784.
28. Mouro I, Colin Y, Chérif-Zahar B, Cartron J-P, Le Van Kim C. Molecular genetic basis of the human Rhesus blood group system. Nature Genet. 1993; 5:62-65.
29. Blunt T, Daniels G, Carritt B. Serotype switching in a partially deleted RHD gene. Vox Sang. 1994; 67:397-401.
30. Smythe JS, Avent ND, Judson PA, Parsons SF, Martin PG, Anstee DJ. Expression of RHD and RHCEgene products using retroviral transduction of K562 cells establishes the molecular basis of Rh blood group antigens. Blood. 1996;87: 2968-2973.
31. Le Van Kim C, Mouro I, Chérif-Zahar B, et al. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Nail AcadSei USA. 1992;89:10,925-10,929.
32. Arce MA, Thompson ES, Wagner S, Coyne KE, Ferdman BA, Lublin DM. Molecular cloning of RhD cDNA derived from a gene present in RhDpositive, but not RhD-negative individuals. Blood. 1993:82:651-655.
33. Chérif-Zahar B, Bloy C, Le Van Kim C, et al. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sei USA. 1990:87:6243-6247.
34. Suyama K, Goldstein J, Aebersold R, Kent S. Regarding the size of Rh proteins. Blood. 1991 ;77: 411.
35. x (Rh9) blood group specificities. Blood. 1995:86:1196-1201.
36. Kajii E, Umenishi F, Iwamoto S, Ikemoto S. Isolation of a new cDNA clone encoding an Rh polypeptide associated with the Rh blood group system. Hum Genet. 1993:91:157-162.
37. de Veiten MP, Agre P. The Rh polypeptide is a major fatty acid-acylated erythrocyle membrane protein. J Biol Chem. 1988:263:18,193-18,196.
38. Basu MK, Flamm M, Schachter D, Bertles JF, Maniatis A. Effects of modulating erythrocyte membrane cholesterol on Rh0(D) antigen expression. Biochem Biophys Res Commun. 1980:95:887893.
39. Ridgwell K, Eyers SA, Mawby WJ, Anstee DJ, Tanner MJ. Studies on the glycoprotein associated with Rh (rhesus) blood group antigen expression in the human red blood cell membrane. J Biol Chem. 1994:269:6410-6416.
40. Southcott MJG, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood. 1999:93:4425-4435.
41. Chown B. On a search for Rhesus antibodies in very young foetuses. Arch Dis Child. 1955;30: 232-233.
42. + transporters. Trends Biochem Sei. 1997;22:460-461.
43. Matassi G, Chérif-Zahar B, Pesole G, Raynal V, Cartron JP. The members of the RH gene family (RH50 and RH30) followed different evolutionary pathways. J Mol Evol. 1999;48:151-159.
44. Lorenz MC, Heitman J. The MEP2 ammonium permease regulates pseudohyphal differentiation in Sacchammyces cerevisiae. EMBO J. 1998;17: 1236-1247.
45. Bailly P, Tontti E, Hermand P, Cartron JP, Gahmberg CG. The red cell LW blood group protein \z an intercellular adhesion molecule which binds to CD11/CD18 leukocyte integrins. Eur J Immunol. 1995:25:3316-3320.
46. Issitt PD, Anstee DJ. Applied Blood Group Serology. Durham, NC: Montgomery Scientific Publications; 1998.
47. Daniels G. Human Blood Groups. Oxford, England: Blackwell Science Ltd; 1995.
48. Giles CM. The LW blood group: a review. Immunol Commun. 1980:9:225-242.
49. Mallinson G, Martin PG, Anstee DJ, et al. Identification and partial characterization of the human erythrocyte membrane component(s) that express the antigens of the LW blood-group system. Biochem J. 1986:234:649-652.
50. Brown E, Hooper L, Ho T, Gresham H. Integrinassociated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins. J Cell Biol. 1990;111:2785-2794.
51. Mawby WJ, Holmes CH, Anstee DJ, Spring FA, Tanner MJ. Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin- associated protein (IAP) and the ovarian tumour marker OA3. Biochem J. 1994:304:525-530.
52. Reinhold Ml, LJndberg FP, Plas D, Reynolds S, Peters MG, Brown EJ. In vivo expression of alternatively spliced forms of integrin-associated protein (CD47). J Ceil Sei. 1995:108:3419-3425.
53. Gao AG, LJndberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem. 1996;271:21 -24.
54. Schwartz MA, Brown EJ, Fazeli B. A 50-kDa integrin-associated protein is required for integrinregulated calcium entry in endothelial cells. J Biol Chem. 1993:268:19,931-19,934.
55. Miller YE, Daniels GL, Jones C, Palmer DK. Identification of a cell-surface antigen produced by a gene on human chromosome 3 (cen-q22) and not expressed by Rhnull cells. Am J Hum Genet. 1987;41:1061-1070.
56. Avent N, Judson PA. Parsons SF, et al. Monoclonal antibodies that recognize different membrane proteins that are deficient in Rhnull human erythrocytes: one group of antibodies reacts with a variety of cells and tissues whereas the other group is enhroid-specific. Biochem J. 1988:251:499-505.
57. Gardner B, Anstee DJ, Mawby WJ, Tanner MJ, von dem Borne AE. The abundance and organization of polypeptides associated with antigens of the Rh blood group system. Transfus Med. 1991 ;1:77-85.
58. Mallinson G, Anstee DJ, Avent ND, et al. Murine monoclonal antibody MB-2D10 recognizes Rhrelated glycoproteins in the human red cell membrane. Transfusion. 1990:30:222-225.
59. Ballas SK, Reilly PA, Murphy DL The blood group U antigen is not located on glycophorin B. Biochim Biophys Acta. 1986:884:337-343.
60. Colledge Kl, Pezzulich M, Marsh WL. Anti-Fy5, and antibody disclosing a probable association between the Rhesus and Duffy blood group genes. Vox Sang. 1973:24:193-199.
61. Tanner MJ. Molecular and cellular biology of the erythrocyte anion exchanger (AE1). Semin Hematol. 1993:30:34-57.
62. Fujinaga J, Tang X-B, Casey JR. Topology of the membrane domain of human erythrocyte anion exchange protein, AE1. J Biol Chem. 1999:274: 6626-6633.
63. Booth PB, Serjeantson S, Woodfield DG, Amato D. Selective depression of blood group antigens associated with hereditary ovalocytosis among Melanesians. Vox Sang. 1977:32:99-110.
64. Tanner MJ, Bruce L, Martin PG, Rearden DM, Jones GL. Melanesian hereditary ovalocytes have a deletion in red cell band 3. Blood. 1991 ; 78:2785-2786.
65. Schofield AE, Reardon DM, Tanner MJ. Defective anion transport activity of the abnormal band 3 in hereditary ovalocytic red blood cells. Nature. 1992:355:836-838.
66. Uu S-C, Palek J, Yi SJ, et al. Molecular basis of altered red blood cell membrane properties in Southeast Asian ovalocytosis: role of the mutant band 3 protein in band 3 oligomerization and retention by the membrane skeleton. Blood. 1995: 86:349-358.
67. Mohandas N, Winardi R, Knowles D, et al. Molecular basis for membrane rigidity of hereditary ovalocytosis: a novel mechanism involving the cytoplasmio domain of band 3. J Clin Invest. 1992:89:686-692.
68. Beckmann R, Smythe JS, Anstee DJ, Tanner MJA. Functional cell surface expression of band 3, the human red blood cell anion exchange protein (AE1), in K562 erythroleukemia cells: band 3 enhances the cell surface reactivity of Rh antigens. Blood. 1998:92:4428-4438.
69. Huang C-H, Chen Y, Reid M, Ghosh S. Genetic recombination at the human RH locus: a family study of the red cell-Evans phenotype reveals a transfer of exons 2-6 from the RHD to the RHCE gene. Am J Hum Genet. 1996:59:825-833.
70. u), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood. 1997:89:2568-2577.
71. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schuhnter F, Flegel WA. Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematological features. Blood. 1998:91:2157-2168.
72. Kemp TJ, Poulter M, Carritt B. A recombination hot spot in the Rh genes revealed by analysis of unrelated donors with the rare D - phenotype. Am J Hum Genet. 1996:59:1066-1073.
73. Westhoff CM, Wylie DE. Investigation of the RH locus in gorillas and chimpanzees. J Mol Evol. 1996:42:658-668.
74. Okuda H, Kawano M, Iwamoto S, et al. The PHD gene is highly detectable in RhD-negative Japanese donors. J Clin Invest. 1997;100:373-379.
75. Matassi G, Chérif-Zahar B, Raynal V, Rouger P, Cartron JP. Organization of the human RH50A gene (RHAG) and evolution of base composition of the RH gene family. Genomics. 1998;47:286-293.
76. Iwamoto S, Omi T, Yamasaki M, Okuda H, Kawano M, Kajii E. Identification of 5' flanking sequence of RH50 gene and the core region for erythroid-specific expression. Biochem Biophys Res Commun. 1998:243:233-240.
77. Kitano T, Sumiyama K, Shiroishi T, Saitou N. Conserved evolution of the Rh50 gene compared to its homologous Rh blood group gene. Biochem Biophys Res Commun. 1998:249:78-85.
78. Wilson R, Ainscough R, Anderson K, et al. 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans. Nature. 1994:368:32-38.
79. Seack J, Pancer Z, Muller IM, Muller WE. Molecular cloning and primary structure of a Rhesus (Rh)-like protein from the marine sponge Geodia cydonium. Immunogenetics. 1997;46:493-498.
80. Apoil PA, Blancher A. Sequences and evolution of mammalian fiHgene transcripts and proteins. Immunogenetics. 1999:49:15-25.
81. Apoil PA, Roubinet F, Blancher A. Gorilla RH-fike genes and antigens. Immunogenetics. 1999;49: 125-133.
82. Blancher A, Klein J, Socha WW. Molecular Biology and Evolution of Blood Group and MHC Antigens in Primates. Berlin: Springer-Vertag; 1997.
83. Carritt B, Kemp TJ, Poulter M. Evolution of the human RH (rhesus) blood group genes: a 50 year old prediction (partially) fulfilled. Hum Mol Genet. 1997:6:843-850.
84. Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron J-P. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood. 1991;78:2747-2752.
85. Avent ND. The Rhesus blood group system: insights from recent advances in molecular biology. Transfus Med Rev. In press.
86. Flegel WA, Wagner FF, Müller TH, Gassner C. Rh phenotype prediction by DNA typing and its application to practice. Transfus Med. 1998:8:281-302.
87. Umenishi F, Kajii E, Ikemoto S. Molecular analysis of Rh polypeptides in a family with RhD-positive and RhD-negative phenotypes. Biochem J. 1994:299:207-211.
88. Hyland CA, Weiter LC, Saul A. Three unrelated Rh D gene polymorphisms identified among blood donors with Rhesus CCee (rT) phenotypes. Blood. 1994:84:321-324.
89. Daniels G, Green C, Smart E. Differences between RhD-negative Africans and RhD-negative Europeans. Lancet. 1997:350:862-863.
90. N phenotypes. Blood. 1996:87:4853-4861.
91. Legier TJ, Maas JH, Blaschke V, et al. RHO genotyping in weak D phenotypes by multiple polymerase chain reactions. Transfusion. 1998; 38:434-440.
92. Wagner FF, Gassner C, Müller TH, Schönitzer D, Schunter F, Flegel WA. Molecular basis of weak D phenotypes. Blood. 1999:93:385-393.
93. Simsek S, de Jong ÇA, Cuijpers HT, et al. Sequence analysis of cDNA derived from reticulocyte mRNAs coding for Rh polypeptides and demonstration of of E/e and C/c polymorphisms. Vox Sang. 1994:67:203-209.
94. Avent ND, Daniels GL, Martin PG, Green CA, Finning KM, Warner KM. Molecular investigation of the Rh C/c polymorphism [abstract]. Transfus Med. 1997;7(suppl 1):18.
95. Blancher A, Socha WW. The Rhesus system. In: Blancher A, Klein J, Socha WW, eds. Molecular Biology and Evolution of Blood Group and MHC Antigens in Primates. Berlin: Springer-Verlag; 1997:147-218.
96. Westhoff CM, Silberstein LE, Wylie DE, Apoil P, Blancher A. Characterization of the Rh locus of the New World capuchin (Cebus ape/fa) monkey [abstract]. Transfusion 1998;38(suppl):102S.
97. Issitt PD. An invited review: the Rh antigen e, its variants, and some closely related serological observations. Immunohematology. 1991;7:29-36.
98. Faas BHW, Beckers EAM, Wildoer P, et al. Molecular background of VS and weak C expression in blacks. Transfusion. 1997;37:38-44.
99. Steers F, Wallace M, Johnson P, Carritt B, Daniels G. Denaturing gradient gel electrophoresis: a novel method for determining Rh phenotype from genomic DMA. Br J Haematol. 1996;94: 417-42).
100. Huang C-H, Reid ME, Chen Y, Novaretti M. Deletion of Arg229 in RhCE polypeptide alters expression of RhE and CE-associated Rh6 [abstract]. Blood. 1997;90(suppl 1):272a.
101. Westhoft CM, Silberstein LE, Sipherd B, et al. Altered "e" antigen expression associated with 16Cys in exon 1 of the RHce gene [abstract]. Transfusion. 1993;38(Suppl):64S.
102. Avent ND, Finning KM, Liu W, Scott ML. Molecular biology of partial D phenotypes. Transfus Clin Biol. 1996:3:511-516.
103. Noizat-Pirenne F, Mouro I, Gane P, et al. Heterogeneity of blood group RhE variants revealed by serological analysis and molecular alteration of the RHCE gene and transcript. Br J Haemalol. 1998:103:429-436.
104. Daniels GL, Faas BHW, Green ÇA, et al. The VS and V blood group polymorphisms in Africans: a serological and molecular analysis. Transfusion. 1998:38:951-958.
105. Faas BHW, Beckers EAM, Simsek S, et al. Involvement of Ser103 of the Rh polypeptides in G epitope formation. Transfusion. 1996:36:506-511.
106. Rouillac C, Le Van Kirn C, Blancher A, Roubinet F, Cartron J-P, Colin Y. Lack of G blood group antigen in D'ntl erythrocytes is associated with segmentai DNA exchange between RH genes. Br J Haematol. 1995:89:424-426.
107. Lomas C, Mougey R. Rh antigen D: variable expression in D"1 phenotypes; a possible subdivision of category VI by a low frequency antigen [abstract]. Transfusion. 1989;29(suppl):14S.
108. VI phenotype. Am J Hum Genet. 1997;60:808-817.
109. Race RR, Sanger R, Selwyn JG. A probable deletion in a human Rh chromosome. Nature. 1950; 166:520-521.
110. Tippett P, Lomas-Francis C, Wallace M. The Rh antigen D: partial D antigens and associated low incidence antigens. Vox Sang. 1996:70:123-131.
111. w+ and Rh32+ red blood cells. Vox Sang. 1998:75:230-233.
112. Lomas C, Tippett P, Thompson KM, Melamed MD, Hughes-Jones NC. Demonstration of seven epitopes on the Rh antigen D using human monoclonal anti-D antibodies and red cells from D categories. Vox Sang. 1989:57:261-264.
113. Lomas C, McCoIl K, Tippett P. Further complexities of the Rh antigen D disclosed by testing cat-egory DM cells with monoclonal anti-D. Transfus Med. 1993;3:67-69.
114. Jones J, Scott ML, Voak D. Monoclonal anti-D specificity and Rh D structure: criteria (or selection of monoclonal anti-D reagents for routine typing of patients and donors. Transfus Med. 1995;5: 171-184.
115. Scött M. Rh serology - Coordinator's report. Transfus Clin Biol. 1996:3:333-337.
116. Apoil PA, Reid ME, Halverson G, et al. A human monoclonal anti-D antibody which detects a nonconformation-dependent epitope on the RhD protein by immunoblotting. Br J Haematol. 1997;98: 365-374.
117. Cartron J-P, Rouillac C, Le Van Kim C, Mouro I, Colin Y. Tentative model for the mapping of D epitopes on the RhD polypeptide. Transfus Clin Biol. 1996:3:497-503.
118. Scott ML, Voak D, Jones JW, et al. A structural model for 30 Rh D epitopes based on serological and DNA sequence data from partial D phenotypes. Transfus Clin Biol. 1996;3:391 -396.
119. Chang TY, Siegel DL. Genetic and immunological properties of phage-displayed human anti-Rh(D) antibodies: implications for Rh(D) epitope topology. Blood. 1998;91:3066-3078.
120. Uu W, Smythe JS, Scott ML, Jones JW, Voak D, Avent ND. Site-directed mutagenesis of the human D antigen: definition of D epitopes on the sixth external domain of the D protein expressed on K562 cells. Transfus. 1999;39:17-25.
121. Zhu A, Haller S, Li H, Chaudhuri A, Blancher A, Suyama K. Use of RhD fusion protein expressed on K562 cell surface in the study of molecular basis for D antigenio epitopes. J Biol Chem. 1999:274:5731-5737.
122. Uu W, Avent ND, Jones JW, Scott ML, Voak D. D epitope localisation using site directed mutagenesis and expression of Rh mutant constructs in K562 cells. Blood. In press.
123. Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine. Oxford, England: Blackwell Science; 1997.
124. Standards Committee of American Association of Blood Banks. Standards for Blood Banks and Transfusion Services. Bethesda, MD: American Associations of Blood Banks; 1999.
125. Petz LD, Garratty G. Acquired Immune Hemolytio Anemias. New York: Churchill Livingstone; 1980.
126. Sloan SR, Silberstein LE. Transfusion in the face of autoantibodies. In: Reid ME, Nance SJ, eds. Red Cell Transfusion: A Practical Guide. Totowa, NJ: Humana Press; 1998:55-70.
127. Vengelen-Tyler V. Technical Manual. Bethesda, MD: American Association of Blood Banks; 1999.
128. Lacey PA, Caskey CR, Wemer DJ, Moulds JJ. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother. Transfusion. 1983:23:91-94.
129. Reid ME, Halverson GR, Roubinet F, Apoil PA, Blancher A. Use of LOR-15C9 monoclonal anti-D to differentiate erythrocytes with the partial D" antigen from those with other partial D antigens or weak D antigens. Immunohematology. 1998; 14:89-93.
130. Bowman JM. The development and use of polyclonal prophylactic anti-D IgG. Biotest Bull. 1997; 5:503-510.
131. Giblett ER. Blood group alloantibodies: an assessment of some laboratory practices. Transfusion. 1977:4:299-308.
132. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red cell transfusions and alloimmunization: experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med. 1995; 119:42-45.
133. Meddle NM, Klama L, Frassetto R, O'Hoski P, Leaman B. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion. 1993;33:217-220.
134. Zupanska B. Assays to predict the clinical significance of blood group antibodies. Curr Opin Hematol. 1998:5:412-416.
135. Ulm B, Svolba G, Dim MR, Bernaschek G, Panzer S. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion. 1999:39:169-173.
136. Lubenko A, Contreras M, Habash J. Should anti-Rh immunoglobulin be given D variant women? Br J Haematol. 1989:72:429-433.
137. Bussel JB, Graziano JN, Kimberiy RP, Pahwa S, Aledort LM. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect [comments]. Blood. 1991;77;1884-1893.
138. Scaradavou A, Woo B, Woloski BMR, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood. 1997:89:2689-2700.
139. + red blood cells and suppression of Rh D immunization in Rh D" volunteers. Blood. 1995;86: 1701-1709.
140. Maaskant-van Wijk PA, Faas BH, de Ruijter JA, et al. Genotyping of PHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion. 1998;38:1015-1021.
141. Pope J, Navarrete C, Warwick R, Contreras M. Multiplex PCR analysis of RhD gene. Lancet. 1995:346:375-376.
142. Stoerker J, Hurwitz C, Rose NC, Silberstein LE, Highsmith WE. Heteroduplex generator in analysis of Rh blood group alleles. Clin Chem. 1996; 42:356-360.
143. Rose NC, Hurwitz C, Silberstein L, Andovalu R, Stoerker J. Prenatal analysis of rhesus CcDEe blood groups by heteroduplex generator. Am J Obstet Gynecol. 1997:176:1084-1089.
144. Aubin JT, Kim CL, Mouro I, et al. Specificity and sensitivity of RHD genotyping methods by PCRbased DNA amplification. BrJ Haematol. 1997; 98:356-364.
145. Gassner C, Schmarda A, Kilga-Nogler S, et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion. 1997:37:1020-1026.
146. Bennett PR, Le Van Kim C, Colin Y, et al. Prenatal determination of fetal RhD type by DNA amplification. N Engl J Med. 1993:329:607-610.
147. Wolter LC, Hyland CA, Saul A. Rhesus D: genotyping using polymerase chain reaction. Blood. 1993:82:1682-1683.
148. Va. Br J Haematol. 1990; 76:537-539.
149. Andrews KT, Wolter LC, Saul A, Hyland CA. The RhD-trait in a white patient with the RhCCee phenotype attributed to a four-nucleotide deletion in the RHD gene. Blood. 1998:92:1839-1840.
150. Singleton BK, Green CA, Avent ND, et al. An RHD pseudogene containing a 37 bp duplication and a nonsense mutation is present in most Africans with the Rh D-negative blood group phenotype. Blood. 2000:95:12-18.
151. Fukumori Y, Hori Y, Ohnoki S, et al. Further analysis of Del (D-elute) using polymerase chain reaction (PCR) with RHD gene-specific primers. Transfus Med. 1997;7:227-231.
152. Sun C-F, Chou CS, Lai NC, Wang WT. RHD gene polymorphisms among RhD-negative Chinese in Taiwan. Vox Sang. 1998:75:52-57.
153. Del is caused by a delation of 1,013 bp between introns 8 and 9 including exon 9 of RHD gene. Blood. 1998:92:2602-2604.
154. Reed W, Lee T-H, Busch MP, Vichinsky EP. Sample suitability for the detection of minor leukocyte populations by polymerase chain reaction (PCR) [abstract]. Transfusion. 1997;37(suppl):107S.
155. IIIa, in Black donors as determined by PCR-RFLP analysis [abstract]. Transfusion. 1998;38(suppl): 63S.
156. Va phenotype. Biochem Biophys Res Commun. 1999;254:786-794.
157. Le Van Kim C, Mouro I, Brassard Y, Chavinie J, Cartron J-P, Colin Y. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease. Br J Haematol. 1994; 88:193-195.
158. Faas BHW, Simsek S, Bleeker PM, et al. Rh E/e genotyping by allele-specific primer amplification. Blood. 1995:85:829-832.
159. Poulter M, Kemp TJ, Carritt B. DNA-based rhesus typing: simultaneous determination of RHC and RHD status using the polymerase chain reaction. Vox Sang. 1996;70:164-168.
160. Lo YM, Bowell PJ, Selinger M, et al. Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers. Lancet. 1993:341:1147-1148.
161. Lo YMD, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997:350:485-487.
162. Lo YMD, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med. 1998:339:17341738.
163. Faas BH, Beuling EA, Christiaens GC, von dem Bome AE, van der School CE. Detection of fetal RHD-specific sequences in maternal plasma. Lancet. 1998:352:1196.
164. Adinolfi M, Sherlock J, Kemp T, et al. Prenatal detection of fetal RhD DNA sequences in transcervical samples. Lancet. 1995:345:318-319.
165. Bennett PR, Overton TG, Lighten AD, Fisk NM. Rhesus D typing. Lancet. 1995:345:661-662.
166. Kingdom J, Sherlock J, Rodeck C, Adinolfi M. Detection of trophoblast cells in transcervical samples collected by lavage or cytobrush. Obstet Gynecol. 1995:86:283-288.
167. Hamlington J, Cunningham J, Mason G, Mueller R, Miller D. Prenatal detection of rhesus D genotype. Lancet. 1997:349:540.
168. Cheung M-C, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet. 1996;14:264-268.
169. Bianchi DW, Zickwolf GK, Weil G J, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. ProcNatlAcad Sei USA. 1996:93:705-708.
170. null disease. Vox Sang. 1972:23:182-189.
171. Ballas SK, Clark MR, Mohandas N, et al. Red cell membrane and cation deficiency in Rh null syndrome. Blood. 1989:63:1046-1055.
172. Nash R, Shojania AM. Hematological aspect of Rh deficiency syndrome: a case report and a review of the literature. Am J Hematol. 1987;24: 267-275.
173. null human erythrocytes have an abnormal membrane phospholipid organization. Biochem J. 1984:221:931-934.
174. Chérif-Zahar B, Raynal V, Gane P, et al. Candi-date gene acting as a suppressor of the RHlocus in most cases of Rh-deficiency. Nat Genet. 1996; 12:168-173.
175. null blood donor of the regulator type. Blood. 1998:91:1458-1463.
176. null dis- ' ease: the amorph type results from a novel double mutation in RhCe gene on D-negative background. Blood. 1988:92:664-671.
177. Chérif-Zahar B, Matassi G, Raynal V, et al. Rhdeficiency of the regulator type caused by splicing mutations in the human RHSOgene. Blood. 1998:92:2535-2540.
178. Reid ME, Bird GW. Associations between human red cell blood group antigens and disease. Transfus Med Rev. 1990:4:47-55.
179. Chérif-Zahar B, Bony V, Steffensen R, et al. Shift from Rh-positive to Rh-negative phenotype caused by a somatic mutation within the RHD gene in a patient with chronic myelocytic leukaemia. Br J Haematol. 1998:102:1263-1270.
180. Chérif-Zahar B, Mattei MG, Le Van Kim C, Bailly P, Cartron J-P, Colin Y. Localization of the human Rh blood group gene structure to chromosome region 1 p34.3-1 p36.1 by in situ hybridization. Hum Genet. 1991:86:398-400.
181. Hermand P, Gane P, Mattei MG, Sistonen P, Cartron J-P, Bailly P. Molecular basis and expression of the LWWLW" blood group polymorphism. Blood. 1995:86:1590-1594.
182. Zelinski T, Coghlan G, White L, Philipps S. The Diego blood group locus is located on chromosome 17q. Genomics. 1993;17:665-666.
183. null erythrocytes. Blut. 1987:54:13-24.
184. W- red blood cells: phenotypic homozygosiry versus genotypic heterozygosity. Blood. 1996:88:2326-2333.
185. Noizat-Pirenne F, Mouro I, Gane P, et al. Molecular analysis of selected Rh variants. Transfus Clin Biol. 1996:3:517-519.
186. Chérif-Zahar B, Raynal V, Cartron JP. Lack of RHCE-encoded proteins in the D - phenotype may result from homologous recombination between the two RHgenes. Blood. 1996:88:1518-1520.
187. Cheng G-J, Chen Y, Reid ME, Huang C-H. Evans antigen: a new hybrid structure occurring on background of D- and D-Rh complexes. Vox Sang. In press.
188. Huang C-H, LJu PZ. Cheng JG. Molecular biology and genetics of the Rh blood group system. Semin Hematol. In press.
189. Chérif-Zahar B, Matassi G, Raynal V, et al. Molecular defects of the RHCE gene in Rh-deficient individuals of the amorph type. Blood. 1998:92: 639-646.
190. VI category phenotype. Blood. 1994:83:1129-1135.
191. Flegel WA, Wagner FF. The frequency of RHD protein variants in Caucasians [abstract]. Transfus din Biol. 1996;3:10S.
192. Avent ND, Jones JW, LJu W, et al. Molecular basis of the D variant phenorypes DNU and D" allows localization of critical amino acids required for expression of Rh D epitopes epD3.4 and 9 to the sixth external domain of the Rh D protein. Br J Haematol. 1997:97:366-371.
193. VII category blood group phenotype. Am J Hematol. 1995:49:87-88.
194. Rouillac C, Colin Y, Hughes-Jones NC, et al. Transcript analysis of D category phenotypes predicts hybrid Rh D-CE-D proteins associated with alteration of D epitopes. Blood. 1995:85:2937-2944.
195. Wagner FF, Gassner C, Eicher N, Lonicer C, Flegel WA. Characterization of D category IV type IV, DFW, and DNB [abstract]. Transfusion. 1998; 38(suppl):63S.
196. Jones JW, Finning K, Mattock R, et al. The serological profile and molecular basis of a new partial D phenotype, DHR. Vox Sang. 1997;73:252-256.
197. IIIa erythrocytes: RhD protein is associated with multiple dispersed amino acid variations. Am J Hematol. 1997;55:139-145.
198. Beckers EA, Faas BH, Ugthart P, et al. Characterization of the hybrid RHD gene leading to the partial D category Illc phenotype. Transfusion. 1996:36:567-574.
199. VIccEe phenotypes. Blood. 1997:89:1779-1786.
200. VI category erythrocytes: correlation of the phenotype with a novel hybrid RhD-CE-D gene but not an internally deleted RhD gene. Blood. 1997:89:1834-1835.
201. Faas BHW, Beckers EAM, Maaskant-van Wijk PA, Overbeeke MAM, Van Rhenen DJ, Von dem Borne AEGK. Molecular characterization of qualitative Rh variants. Biotest Bull. 1997:5:439-449.
202. DBT. Br J Haematol. 1996;93:720-727.
203. Huang C-H, Chen Y, Reid ME, Okubo Y. Evidence for a separate genetic origin of the partial D phenotype DBT in a Japanese family. Transfusion. In press.
204. Hemker M, Ligthart PC, Faas BHW, et al. ARRO-I: a new partial D phenotype involving exon 4 and 5 [abstact]. Vox Sang. 1998;74(suppl 1):1331.
205. Pisacka M, Vytiskov́ J, Hejná J, Gassner C. A new variant of Rh(D) antigen: revealed by reactions of anti-ep12 monoclonal antibodies and lacking exon 5 D-specific reaction of exon-scanning RHD/CE PCR-SSP [abstract]. Vox Sang. 1998;74(suppl1):1332.
206. Faas BHW, Ligthart PC, Lomas-Francis C, Overbeeke MAM, von dem Borne AEG, van der School CE. Involvement of Gly96 in the formation oftheRh26epitope. Transfusion. 1997;37:1123-1130.
207. 0HarRh:33 phenotype results from substitution of exon 5 of the RHCE gene by the corresponding exon of the RHD gene. BrJ Haematol. 1996:92:751-757.
208. Mouro I, Colin Y, Gane P, et al. Molecular analysis of blood group Rh transcripts from a r°r variant. BrJ Haematol. 1996:93:472-474.
209. Huang CH, Cheng GJ, Reid ME, Chen Y. Rhyndrome: a family study of the translation-initiator mutation in the Rh50 glycoprotein gene. Am J Hum Genet. 1999:64:108-117.
210. null syndrome: identification of three new missense mutations in the Rh50 glycoprotein gene. Am J Hematol. In press.
211. Okuda H, Suganuma H, Tsudo N, Omi T, Iwamoto S, Kajii E. Sequence analysis of the spacer region between the RHD ana RHCE genes. Biochem Biophys Res Commun. 1999:263:378-383.